McKesson | MCK - Sales Revenues


McKesson reported $105.38B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Acadia Healthcare USD 865.8M 37M Jun/2026
Align Technology USD 1.02B 40M Sep/2026
Cardinal Health USD 63.7B 2.8B Jun/2026
Centene USD 50.65B 2.93B Sep/2026
Charles River Laboratories USD 1000M 4.2M Jun/2026
Cigna USD 71.7B 3.18B Jun/2026
Community Health Systems USD 3.11B 19M Dec/2025
CVS Health USD 106.1B 5.7B Jun/2026
DaVita Healthcare Partners USD 3.55B 130M Jun/2026
Dentsply International USD 898M 18M Jun/2026
eHealth USD 58.41M 7.45M Sep/2024
Elevance Health USD 51.43B 1.63B Sep/2026
Encompass Health USD 1.61B 10M Sep/2026
HCA USD 19.85B 380M Sep/2026
Henry Schein USD 3.46B 90M Jun/2026
Humana USD 40.89B 1.24B Jun/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
J&J USD 25.4B 89M Sep/2026
Laboratory Of America USD 3.81B 80M Sep/2026
McKesson USD 105.38B 13.08B Jun/2026
Molina Healthcare USD 11.08B 212M Sep/2026
Owens Minor USD 708.97M 11.71M Dec/2025
Quest Diagnostics USD 3.1B 57M Sep/2026
Stryker USD 6.6B 600M Jun/2026
Tenet Healthcare USD 5.63B 0 Sep/2026
UnitedHealth USD 112.69B 694M Sep/2026
Universal Health Services USD 4.73B 90M Sep/2026
Veradigm USD 142.52M 9.38M Dec/2022